HDFC Pharma and Healthcare Fund - Growth Option
| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 04-10-2023 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare Index |
| Expense Ratio: 2.02% As on (31-05-2025) |
| Status: Open Ended Schemes |
| Minimum Investment: 100.0 |
| Minimum Topup: 100.0 |
| Total Assets: 1,704.29 Cr As on (30-05-2025) |
| Turn over: - |
PERFORMANCE of HDFC Pharma and Healthcare Fund - Growth Option
Scheme Performance (%)
Data as on - 04-07-2025Yearly Performance (%)
Fund Managers
FM 1 - Mr. Nikhil Mathur, FM 2 - Mr. Dhruv Muchhal
Investment Objective
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
RETURNS CALCULATOR for HDFC Pharma and Healthcare Fund - Growth Option
Growth of 10000 In SIP (Fund vs Benchmark)
Growth of 10000 In LUMPSUM (Fund vs Benchmark)
Rolling Returns
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Riskometer
Key Performance and Risk Statistics of HDFC Pharma and Healthcare Fund - Growth Option
| Key Statistics | Volatility | Sharpe Ratio | Alpha | Beta | Yield to Maturity | Average Maturity |
|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund - Growth Option | - | - | - | - | - | - |
| Equity: Sectoral-Pharma and Healthcare | - | - | - | - | - | - |
